Brokerages Set U.S. Physical Therapy, Inc. (NYSE:USPH) Target Price at $114.00

U.S. Physical Therapy, Inc. (NYSE:USPH) has received an average rating of “Buy” from the five brokerages that are currently covering the firm, MarketBeat reports. Four equities research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month price objective among brokers that have covered the stock in the last year is $114.00.

Several brokerages have issued reports on USPH. Citizens Jmp raised shares of U.S. Physical Therapy to a “strong-buy” rating in a research note on Monday, December 16th. Bank of America raised shares of U.S. Physical Therapy from a “neutral” rating to a “buy” rating and upped their price objective for the company from $100.00 to $115.00 in a research note on Monday, December 16th. JMP Securities initiated coverage on shares of U.S. Physical Therapy in a report on Monday, December 16th. They issued an “outperform” rating and a $113.00 price objective for the company. Barrington Research restated an “outperform” rating and set a $108.00 target price on shares of U.S. Physical Therapy in a report on Thursday, November 21st. Finally, JPMorgan Chase & Co. increased their price target on U.S. Physical Therapy from $117.00 to $120.00 and gave the company an “overweight” rating in a report on Tuesday, December 3rd.

U.S. Physical Therapy Price Performance

Shares of U.S. Physical Therapy stock opened at $90.26 on Wednesday. The stock has a market capitalization of $1.36 billion, a P/E ratio of 96.02, a PEG ratio of 4.23 and a beta of 1.46. The business has a 50 day simple moving average of $91.12 and a two-hundred day simple moving average of $89.56. U.S. Physical Therapy has a 12 month low of $76.18 and a 12 month high of $113.63. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.78 and a quick ratio of 1.78.

U.S. Physical Therapy Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, December 6th. Investors of record on Friday, November 15th were paid a dividend of $0.44 per share. The ex-dividend date of this dividend was Friday, November 15th. This represents a $1.76 annualized dividend and a yield of 1.95%. U.S. Physical Therapy’s payout ratio is 187.23%.

Insiders Place Their Bets

In other U.S. Physical Therapy news, CFO Carey P. Hendrickson sold 516 shares of U.S. Physical Therapy stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $96.25, for a total transaction of $49,665.00. Following the completion of the sale, the chief financial officer now directly owns 20,469 shares of the company’s stock, valued at $1,970,141.25. The trade was a 2.46 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Bernard A. Harris, Jr. sold 2,000 shares of the company’s stock in a transaction dated Tuesday, November 12th. The stock was sold at an average price of $92.95, for a total value of $185,900.00. Following the transaction, the director now directly owns 16,726 shares of the company’s stock, valued at approximately $1,554,681.70. This represents a 10.68 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 7,412 shares of company stock worth $706,605 in the last quarter. 1.70% of the stock is owned by company insiders.

Institutional Investors Weigh In On U.S. Physical Therapy

Several institutional investors have recently added to or reduced their stakes in USPH. State Street Corp increased its stake in U.S. Physical Therapy by 17.5% in the third quarter. State Street Corp now owns 667,868 shares of the company’s stock valued at $56,522,000 after purchasing an additional 99,244 shares during the last quarter. Southernsun Asset Management LLC grew its position in shares of U.S. Physical Therapy by 10.5% in the 3rd quarter. Southernsun Asset Management LLC now owns 547,111 shares of the company’s stock valued at $46,302,000 after buying an additional 52,062 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in U.S. Physical Therapy by 2.5% during the 2nd quarter. Dimensional Fund Advisors LP now owns 423,846 shares of the company’s stock worth $39,173,000 after acquiring an additional 10,462 shares in the last quarter. Geode Capital Management LLC lifted its position in U.S. Physical Therapy by 1.3% in the third quarter. Geode Capital Management LLC now owns 343,073 shares of the company’s stock valued at $29,040,000 after acquiring an additional 4,477 shares during the last quarter. Finally, Envestnet Asset Management Inc. boosted its stake in U.S. Physical Therapy by 4.1% in the second quarter. Envestnet Asset Management Inc. now owns 239,982 shares of the company’s stock valued at $22,179,000 after acquiring an additional 9,434 shares in the last quarter.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.